{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:09:23Z","timestamp":1793657363448,"version":"4.5.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.06.003","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:26:53Z","timestamp":1277080013000},"page":"599-612","source":"Crossref","is-referenced-by-count":599,"title":["Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data"],"prefix":"10.1016","volume":"29","author":[{"given":"James J.","family":"Sejvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin S.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Gidudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale R.","family":"Burwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Cornblath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cleerbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najwa","family":"Khuri-Bulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Korinthenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"Maltezou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Nell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Oleske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Velentgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Wiznitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"31","key":"10.1016\/j.vaccine.2010.06.003_bib0005","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1016\/j.vaccine.2007.02.063","article-title":"The development of standardized case definitions and guidelines for adverse events following immunization","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"issue":"9497","key":"10.1016\/j.vaccine.2010.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain\u2013Barre syndromes","volume":"10","author":"Willison","year":"2005","journal-title":"J Peripher Nerv Syst"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.06.003_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain\u2013Barre syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0025","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/ana.410270703","article-title":"Guillain\u2013Barre syndrome: historical aspects","volume":"27 Suppl","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2010.06.003_bib0030","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/ana.410270704","article-title":"The epidemiology of Guillain\u2013Barre syndrome","volume":"27","author":"Alter","year":"1990","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00019052-200110000-00009","article-title":"Epidemiology of the Guillain\u2013Barre syndrome","volume":"14","author":"Govoni","year":"2001","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain\u2013Barre Syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0045","first-page":"249","article-title":"Epidemiology of Guillain\u2013Barre syndrome","volume":"19","author":"Schoenberg","year":"1978","journal-title":"Adv Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.06.003_bib0050","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain\u2013Barre syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1385\/NCC:1:4:415","article-title":"Respiratory dysfunction in Guillain\u2013Barre syndrome","volume":"1","author":"Orlikowski","year":"2004","journal-title":"Neurocrit Care"},{"issue":"12","key":"10.1016\/j.vaccine.2010.06.003_bib0060","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1212\/WNL.54.12.2311","article-title":"Long-term outcome in patients with Guillain\u2013Barre syndrome requiring mechanical ventilation","volume":"54","author":"Fletcher","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0065","series-title":"Handbook of Clinical Neurophysiology","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1567-4231(09)70095-4","article-title":"Guillain\u2013Barre syndrome","author":"Cornblath","year":"2006"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.003_bib0070","first-page":"663","article-title":"Guillain\u2013Barre syndrome in children","volume":"7","author":"Jones","year":"1995","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0075","first-page":"191","article-title":"Guillain\u2013Barre syndrome in children","volume":"19","author":"Sladky","year":"2004","journal-title":"J Child Neurol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.06.003_bib0080","first-page":"777","article-title":"Prognostic factors in Guillain\u2013Barre\u2019 syndrome","volume":"42","author":"Singh","year":"1994","journal-title":"J Assoc Phys India"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","article-title":"Epidemiological study of Guillain\u2013Barre syndrome in south east England","volume":"64","author":"Rees","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/088307380001500308","article-title":"New concepts of Guillain\u2013Barre syndrome","volume":"15","author":"Asbury","year":"2000","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain\u2013Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.wco.0000173284.25581.2f","article-title":"Recent developments in Miller Fisher syndrome and related disorders","volume":"18","author":"Overell","year":"2005","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000008201","article-title":"Miller Fisher syndrome: a hospital-based retrospective study","volume":"44","author":"Yuan","year":"2000","journal-title":"Eur Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain\u2013Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barre Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of the motor-sensory axonal Guillain\u2013Barre syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.06.003_bib0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/01616412.1998.11740573","article-title":"Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome","volume":"20","author":"Mizoguchi","year":"1998","journal-title":"Neurol Res"},{"issue":"21","key":"10.1016\/j.vaccine.2010.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain\u2013Barre syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2010.06.003_bib0135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/CVI.00065-06","article-title":"Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain\u2013Barre syndrome","volume":"13","author":"Schmidt-Ott","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.003_bib0145","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.52.6.1282","article-title":"Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain\u2013Barre syndrome","volume":"52","author":"Mori","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.003_bib0150","first-page":"1056","article-title":"Infectious agents as the triggers for the pathogenesis of the neuroimmunological disorders","volume":"66","author":"Nakamura","year":"2008","journal-title":"Nippon Rinsho"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.003_bib0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000115123.42929.FD","article-title":"Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry","volume":"62","author":"Susuki","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.vaccine.2010.06.003_bib0160","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3201\/eid1212.051032","article-title":"Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain\u2013Barre syndrome, England","volume":"12","author":"Tam","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0165","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/mus.20569","article-title":"Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma","volume":"34","author":"Wanschitz","year":"2006","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mus.20394","article-title":"Neurologic complications after surgery for obesity","volume":"33","author":"Koffman","year":"2006","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jnr.20137","article-title":"Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing","volume":"77","author":"Kalume","year":"2004","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ana.410440115","article-title":"Neuronal molecular mimicry in immune-mediated neurologic disease","volume":"44","author":"Levin","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0185","series-title":"Postinfectious Demyelinating Disease","year":"1998"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/jaut.2000.0489","article-title":"Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection","volume":"16","author":"Miller","year":"2001","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0195","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.169.5.2719","article-title":"Functional activation of myelin-specific T cells by virus-induced molecular mimicry","volume":"169","author":"Olson","year":"2002","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/1531-8249(199905)45:5<595::AID-ANA7>3.0.CO;2-M","article-title":"Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis","volume":"45","author":"Piyasirisilp","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.37.4.550","article-title":"Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies","volume":"37","author":"Hemachudha","year":"1987","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.vaccine.2010.06.003_bib0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM198702123160703","article-title":"Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination","volume":"316","author":"Hemachudha","year":"1987","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.003_bib0215","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/014107687907200908","article-title":"Guillain\u2013Barre syndrome: the swine influenza virus vaccine incident in the United States of America, 1976\u201377: preliminary communication","volume":"72","author":"Langmuir","year":"1979","journal-title":"J R Soc Med"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589624","article-title":"Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain\u2013Barre syndrome","volume":"198","author":"Nachamkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2010.06.003_bib0230","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain\u2013Barre syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2010.06.003_bib0235","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain\u2013Barre syndrome in the United Kingdom, 1992 to 2000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Intern Med"},{"issue":"20","key":"10.1016\/j.vaccine.2010.06.003_bib0240","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.003_bib0245","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/oxfordjournals.aje.a115974","article-title":"Guillain\u2013Barre syndrome and influenza vaccination in the US Army, 1980\u20131988","volume":"133","author":"Roscelli","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0250","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.33.5.633","article-title":"Guillain\u2013Barre syndrome in the United States, 1978\u20131981: additional observations from the national surveillance system","volume":"33","author":"Kaplan","year":"1983","journal-title":"Neurology"},{"issue":"25","key":"10.1016\/j.vaccine.2010.06.003_bib0255","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.003_bib0260","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain\u2013Barre syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0265","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain\u2013Barre syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0270","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/ana.410270706","article-title":"Electrophysiology in Guillain\u2013Barre syndrome","volume":"27 Suppl","author":"Cornblath","year":"1990","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jnnp.2007.118000","article-title":"Neurophysiological criteria in the diagnosis of different clinical types of Guillain\u2013Barre syndrome","volume":"79","author":"Kalita","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0280","first-page":"CD001798","article-title":"Plasma exchange for Guillain\u2013Barre syndrome","author":"Raphael","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.003_bib0285","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain\u2013Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0290","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain\u2013Barre syndrome","author":"Hughes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"306","key":"10.1016\/j.vaccine.2010.06.003_bib0295","first-page":"751","article-title":"Plasma exchange treatment and prognosis of Guillain\u2013Barre syndrome","volume":"85","author":"Smith","year":"1992","journal-title":"Q J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/106002809202600108","article-title":"High-dose intravenous immune globulin in the management of severe Guillain\u2013Barre syndrome","volume":"26","author":"Urtasun","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0305","first-page":"CD001446","article-title":"Corticosteroids for treating Guillain\u2013Barre syndrome","author":"Hughes","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0310","first-page":"22","article-title":"Do corticosteroids influence the disease course or mortality in Guillain\u2013Barre syndrome?","volume":"44","author":"Singh","year":"1996","journal-title":"J Assoc Physicians India"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.003_bib0315","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.37.9.1493","article-title":"Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings","volume":"37","author":"Fross","year":"1987","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.003_bib0320","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s004150050505","article-title":"The frequency of clinical variants of Guillain\u2013Barre syndrome in Ferrara, Italy","volume":"246","author":"Govoni","year":"1999","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.06.003_bib0325","first-page":"497","article-title":"Miller Fisher syndrome: axonal, demyelinating or both?","volume":"40","author":"Scelsa","year":"2000","journal-title":"Electromyogr Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.003_bib0330","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.wnl.0000167549.09664.b8","article-title":"Distinguishing acute-onset CIDP from Guillain\u2013Barre syndrome with treatment related fluctuations","volume":"65","author":"Ruts","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0335","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Van den Bergh","year":"2004","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0340","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1542\/peds.111.3.525","article-title":"Interpretation of traumatic lumbar punctures: who can go home?","volume":"111","author":"Mazor","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0345","series-title":"Nelson Textbook of Pediatrics","first-page":"1973","article-title":"Neurologic Evaluation","author":"Haslan","year":"2004"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0350","series-title":"Infancy and Toddler Years","author":"Zuckermann","year":"1999"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.003_bib0355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/pb.2000.6690","article-title":"Guillain\u2013Barre syndrome: perspectives with infants and children","volume":"7","author":"Jones","year":"2000","journal-title":"Semin Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0360","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0022-510X(71)90010-4","article-title":"Diagnostic criteria for the Guillain\u2013Barre syndrome. An analysis of 50 cases","volume":"13","author":"Masucci","year":"1971","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2010.06.003_bib0365","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.410300618","article-title":"Current diagnostic criteria for Guillain\u2013Barre syndrome","volume":"30","author":"van der Meche","year":"1991","journal-title":"Ann Neurol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2010.06.003_bib0370","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.003_bib0375","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp.59.5.482","article-title":"Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain\u2013Barre syndrome. Dutch Guillain\u2013Barre Study Group","volume":"59","author":"Meulstee","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2010.06.003_bib0380","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Efficacy Guidelines, New Codification as per November 2005 (E2A-E) [cited 2009 November 23]; Available from: http:\/\/www.ich.org\/cache\/compo\/276-254-1.html."},{"key":"10.1016\/j.vaccine.2010.06.003_bib0385","unstructured":"Council for International Organizations of Medical Sciences. Suspect Adverse Reaction Report Form (CIOMS I Form). August 3, 2009 [cited 2009 November 23]; Available from: http:\/\/www.cioms.ch\/."},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0390","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/WNL.38.3.375","article-title":"Immunologic studies of rabies vaccination-induced Guillain\u2013Barre syndrome","volume":"38","author":"Hemachudha","year":"1988","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.vaccine.2010.06.003_bib0395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2105\/AJPH.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement","volume":"94","author":"Des Jarlais","year":"2004","journal-title":"Am J Public Health"},{"issue":"9193","key":"10.1016\/j.vaccine.2010.06.003_bib0400","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-Analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2010.06.003_bib0405","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.vaccine.2010.06.003_bib0410","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.003_bib0415","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"52","key":"10.1016\/j.vaccine.2010.06.003_bib0420","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2008.10.006","article-title":"A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"26","author":"Gidudu","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2010.06.003_bib0425","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1000798X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1000798X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:21:09Z","timestamp":1685640069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1000798X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X1000798X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}